TBF-24002-11014
4 vaccinations
4 coded responses
47 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
8AS-12075-95680
Child or adolescent in my care · Female · 2022-06-24
XAC-40065-49354
Child or adolescent in my care · Male · 2022-09-29
Timeline
-
2021-04-17
Registered in v-safe
-
2021-04-17
Dose 1 — Pfizer-BioNTech
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-01
-
2021-05-08
Dose 2 — Pfizer-BioNTech
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-06-12
- 2021-06-19
- 2021-08-07
-
2021-11-06
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2021-11-11
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-15
- 2021-11-17
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-16
- 2021-12-23
- 2022-02-10
- 2022-05-12
- 2022-11-11
-
2023-01-23
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2023-01-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2023-01-27
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction, Poor quality sleep — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2024-11
- 2023-01-28
- 2023-01-29
- 2023-01-30
- 2023-02-06
- 2023-02-13
- 2023-02-20
- 2023-02-27
- 2023-03-06
-
2023-04-24
Survey response — 3 months, dose 4MedDRA: Cough, Muscle fatigue, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Pfizer-BioNTech | |
| 2 | 2021-05-08 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2023-01-23 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Muscle fatigue | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Poor quality sleep | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release